A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
Authors
Thijs van der Vaart (ORCID: https://orcid.org/0000-0002-3858-4027)
J. C. Tonn (ORCID: https://orcid.org/0009-0004-1756-423X)
Susan Chang (ORCID: https://orcid.org/0000-0003-3521-364X)
Jacob S. Young (ORCID: https://orcid.org/0000-0002-5499-4325)
Mitchel Stuart Berger (ORCID: https://orcid.org/0000-0003-1983-4892)
Alba Corell (ORCID: https://orcid.org/0000-0002-6329-2392)
Jong Hee Chang (ORCID: https://orcid.org/0000-0003-1509-9800)
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
Thijs van der Vaart, J. C. Tonn, Susan Chang, Jacob S. Young et al.
Citations
8 citations
Journal
The Lancet Oncology
Topics
Glioma Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
13.00
article
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
Thijs van der Vaart, J. C. Tonn, Susan Chang, Jacob S. Young, Mitchel Stuart Berger, Alba Corell, Jong Hee Chang, Levin Häni, Martin J. van den Bent, Arnaud J.P.E. Vincent, Stefan Josef Grau, Daniel P. Cahill, Michael Weller, Yae Won Park, Roland Goldbrunner, Maarten M.J. Wijnenga, Einar Osland Vik-Mo, Gilbert Youssef, Nicolas Neidert, Bernhard Meyer, Andreas Raabe, Annette M. Molinaro, Sung Soo Ahn, Philipp Karschnia, Shawn L. Hervey‐Jumper, Oliver Schnell, Nitin Tandon, Chad A. Tuchek, Marco Rossi, Jörg Dietrich, Nico Teske, Patrick Y Wen, Arthur Wagner, Raymond Y. Huang, Eduardo Erasmo Mendoza Mireles, Marco Conti Nibali, Stephanie T. Jünger, Felix Ehret, Antonio Dono, Francesco Bruno, Jürgen Beck, Tommaso Sciortino, Lorenzo Bello, Asgeir Store Jakola, Yoshua Esquenazi, Roberta Rudà, Michael A. Vogelbaum, Lorenzo Gay, Alfred Gramelt
article en
8 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet OncologyVol. 26(12)
Institutions
University of Bern (CH), Oslo University Hospital (NO), Harvard University (US), University of Freiburg (DE), University of Cologne (DE), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), University of Oslo (NO), Yonsei University (KR), University of Zurich (CH), University Hospital of Bern (CH), Sahlgrenska University Hospital (SE), Moffitt Cancer Center (US), Massachusetts General Hospital (US), Universitätsklinikum Erlangen (DE), University Hospital of Zurich (CH), Dana-Farber Cancer Institute (US), Woman's Hospital (US), Erasmus MC Cancer Institute (NL), The University of Texas Health Science Center (US), University of Turin (IT), Technical University of Munich (DE), University of San Francisco (US), Ludwig-Maximilians-Universität München (DE), University of Gothenburg (SE)
Funders
U.S. Department of Defense, Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Boston Scientific Corporation, Novocure, Accuray, Boston Pharmaceuticals, Deutsche Krebshilfe, Servier, Medac, National Institutes of Health